ERBB2 and neoplasm: Two key signaling pathways activated by HER2 are the mitogen-activated protein kinases (MAPK) pathway, which stimulates proliferation, and the phosphatidylinositol 3 kinase–protein kinase B (PI3K–Akt) pathway, which promotes tumor cell survival [16].